Crawford-B
CRD.B
12.13
0.00
0.00%
Crawford-B
US · CRD.B
#3652 by market cap
12.13
0.00
0.00%
Live - 5344 symbols - heartbeat 48s ago
· 2026-10-07 19:54
After-hours
12.13
0.00%
- Market cap
- 577.29M
- P/E (TTM)i
- 25.27
- P/Bi
- 3.10
- EPSi
- 0.40
- Div yieldi
- 2.47%
- 52W posi
- 70%
Reader sentiment
Are you bullish or bearish on CRD.B?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.11, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -2.25% YoY
Margins
- Gross margin
- 28.00%
- Operating margin
- 5.56%
- Net margin
- 1.50%
Key ratios & quality
- Enterprise valuei
- 729.90M
- Altman Z-Scorei
- 3.11
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.12B | 1.05B | 1.02B | 1.14B | 1.23B | 1.32B | 1.34B | 1.31B |
| Gross profit | 314.97M | 294.85M | 278.88M | 291.80M | 306.35M | 359.07M | 367.55M | 367.09M |
| Selling & admin expenses | 242.42M | 227.17M | 218.95M | 244.85M | 255.75M | 286.51M | 299.66M | 294.17M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 72.55M | 67.68M | 59.92M | 46.95M | 50.60M | 72.57M | 67.88M | 72.92M |
| Pretax profit | 44.13M | 23.64M | 39.09M | 43.86M | 5.05M | 47.36M | 41.11M | 34.60M |
| Tax | 18.54M | 14.11M | 12.01M | 13.32M | 23.58M | 17.10M | 14.58M | 14.92M |
| Net profit | 25.59M | 9.53M | 27.08M | 30.55M | -18.53M | 30.26M | 26.53M | 19.68M |
| Basic EPS | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 |
| Diluted EPS | 0.50 | 0.26 | 0.54 | 0.57 | -0.37 | 0.61 | 0.53 | 0.39 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 323.34M | 334.60M | 332.81M | 320.09M | 320.13M | 330.02M |
| Gross profit | 90.14M | 98.27M | 93.79M | 84.88M | 88.11M | 94.99M |
| Selling & admin expenses | 74.59M | 78.34M | 71.80M | 64.64M | 76.14M | 69.66M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 15.55M | 19.94M | 21.99M | 20.25M | 11.97M | 25.33M |
| Pretax profit | 9.22M | 13.67M | 18.20M | -6.49M | 7.29M | 19.66M |
| Tax | 2.48M | 5.85M | 5.81M | 786.00K | 2.38M | 6.24M |
| Net profit | 6.74M | 7.82M | 12.39M | -7.27M | 4.91M | 13.42M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.13 | 0.16 | 0.25 | -0.15 | 0.10 | 0.27 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 320.85M | 315.21M | 302.00M | 345.92M | 351.27M | 369.35M | 374.23M | 352.41M |
| Cash & ST investments | 53.12M | 51.80M | 44.66M | 53.23M | 46.01M | 58.36M | 55.41M | 64.08M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 701.44M | 760.01M | 752.98M | 852.64M | 791.51M | 799.20M | 803.76M | 764.30M |
| Total current liabilities | 225.31M | 236.27M | 242.79M | 303.86M | 279.49M | 299.29M | 299.73M | 309.57M |
| Short-term debt | 23.28M | 59.31M | 34.58M | 35.94M | 49.96M | 39.16M | 42.36M | 66.15M |
| Long-term debt | 167.12M | 148.35M | 111.29M | 163.98M | 211.64M | 194.27M | 200.24M | 150.55M |
| Total liabilities | 520,496,000.00 | 595,136,000.00 | 566,056,000.00 | 641,242,000.00 | 668,129,000.00 | 659,368,000.00 | 648,204,000.00 | 592,868,000.00 |
| Total equity | 180.95M | 164.88M | 186.93M | 211.40M | 123.38M | 139.83M | 155.55M | 171.43M |
| Retained earnings | 273.61M | 249.55M | 265.25M | 266.37M | 213.09M | 228.56M | 237.95M | 233.71M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 372.84M | 376.17M | 371.68M | 352.41M | 368.33M | 362.79M |
| Cash & ST investments | 57.37M | 58.53M | 68.77M | 64.08M | 54.49M | 69.42M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 792.26M | 799.37M | 799.84M | 764.30M | 771.65M | 758.25M |
| Total current liabilities | 286.20M | 281.11M | 274.28M | 309.57M | 323.25M | 305.36M |
| Short-term debt | 64.94M | 46.45M | 47.49M | 66.15M | 70.42M | 75.19M |
| Long-term debt | 205.27M | 202.66M | 196.81M | 150.55M | 150.59M | 150.58M |
| Total liabilities | 633,236,000.00 | 624,024,000.00 | 614,160,000.00 | 592,868,000.00 | 597,192,000.00 | 573,734,000.00 |
| Total equity | 159.02M | 175.34M | 185.68M | 171.43M | 174.46M | 184.52M |
| Retained earnings | 241.18M | 245.50M | 251.51M | 233.71M | 229.96M | 236.57M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 52.42M | 75.22M | 93.18M | 54.32M | 27.63M | 103.79M | 51.62M | 101.85M |
| Depreciation & amortization | 44.08M | 40.51M | 40.11M | 40.18M | 36.10M | 35.74M | 36.20M | 40.04M |
| Free cash flow | 22.40M | 54.09M | 55.80M | 23.37M | -6.97M | 67.19M | 9.97M | 63.30M |
| Dividends paid | -13.53M | -13.17M | -9.65M | -12.66M | -11.84M | -12.70M | -13.76M | -14.33M |
| Stock buybacks / issuance | -10.41M | -26.21M | -2.67M | -19.13M | -26.75M | -2.73M | -3.87M | -10.51M |
| Ending cash balance | 53.12M | 51.80M | 44.66M | 53.69M | 46.65M | 59.55M | 56.33M | 64.55M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -13.92M | 35.01M | 30.63M | 50.13M | 3.27M | 19.87M |
| Depreciation & amortization | 9.65M | 9.81M | 10.08M | 10.50M | 9.59M | 9.50M |
| Free cash flow | -23.25M | 25.84M | 21.53M | 39.17M | -4.59M | 12.49M |
| Dividends paid | -3.46M | -3.46M | -3.72M | -3.69M | -3.66M | -3.65M |
| Stock buybacks / issuance | 0 | 0 | -2.95M | -7.56M | -5.52M | -3.52M |
| Ending cash balance | 58.02M | 58.92M | 69.12M | 64.55M | 64.44M | 73.81M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 14.69 | 7.55 | 16.34 | 15.39 | -10.88 | 23.00 | 17.80 | 11.89 |
| ROA %i | 3.49 | 1.71 | 3.74 | 3.82 | -2.23 | 3.85 | 3.32 | 2.50 |
| ROIC %i | 8.67 | 4.99 | 7.67 | 7.61 | -3.77 | 8.98 | 8.15 | 6.86 |
| 5-year avg ROE %i | 8.55 | 6.77 | 16.39 | 14.09 | 8.62 | 10.28 | 12.33 | 11.44 |
| EBIT margin %i | 4.94 | 3.36 | 4.65 | 4.46 | 4.11 | 5.10 | 4.58 | 4.01 |
| FCF / sales %i | 1.99 | 5.16 | 5.49 | 2.05 | -- | 5.10 | 0.74 | 4.83 |
| Current ratioi | 1.42 | 1.33 | 1.24 | 1.14 | 1.26 | 1.23 | 1.25 | 1.14 |
| Quick ratioi | 1.32 | 1.23 | 1.12 | 1.02 | 1.15 | 1.04 | 1.11 | 1.00 |
| Debt / assetsi | 27.15 | 38.79 | 31.82 | 33.86 | 43.76 | 38.98 | 38.51 | 35.36 |
| LT debt / equityi | 97.57 | 147.80 | 109.65 | 119.23 | 238.02 | 192.32 | 169.92 | 117.93 |
| Interest coveragei | 4.87 | 3.05 | 5.77 | 7.28 | -- | 3.39 | 3.02 | 2.93 |
| Revenue CAGR (3Y) %i | -3.29 | -3.82 | -4.42 | 0.48 | 5.53 | 9.03 | 5.59 | 2.11 |
| Net income CAGR (3Y) %i | -- | -29.72 | 0.75 | 5.72 | -- | 2.65 | -4.66 | -- |
| FCF CAGR (3Y) %i | -7.97 | -8.09 | -- | 1.42 | -- | 6.39 | -24.71 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 19.94 | 18.06 | 18.72 | 11.89 | 10.60 | 12.95 |
| ROA %i | 3.88 | 3.74 | 4.07 | 2.50 | 2.28 | 3.02 |
| ROIC %i | 8.64 | 8.33 | 8.69 | 6.86 | 5.51 | 6.58 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.96 | 4.96 | 5.18 | 4.01 | 3.77 | 4.16 |
| FCF / sales %i | 1.19 | 2.89 | 3.89 | 4.83 | 6.27 | 5.27 |
| Current ratioi | 1.30 | 1.34 | 1.36 | 1.14 | 1.14 | 1.19 |
| Quick ratioi | 1.16 | 1.23 | 1.22 | 1.00 | 0.99 | 1.09 |
| Debt / assetsi | 41.83 | 38.72 | 38.20 | 35.36 | 35.13 | 35.70 |
| LT debt / equityi | 165.93 | 148.70 | 137.77 | 117.93 | 113.84 | 104.87 |
| Interest coveragei | 3.26 | 3.34 | 3.63 | 2.93 | 2.97 | 3.49 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- International Operations is the largest reported line at 41.80% of revenue, across 4 reported segments.
- No single line clears half of revenue; Broadspire is next at 33.16%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
International Operations41.80%
Broadspire33.16%
U.S. Property & Casualty22.44%
Reimbursements2.60%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.